(1)
Arafat, A. M. A.; Botros, S. K. A.; Afifi, R.; Zayed, S. A.; Fateen, M. Serum Level of High-Mobility Group Box Protein 1 As a Potential Treatment Target in Egyptian Sickle Cell Disease Patients. Open Access Maced J Med Sci 2022, 10, 1072-1078.